NBP
NBP
Company information not available. Track real-time insider trading activity, SEC Form 4 filings, and executive stock transactions.
Insider Buys
1
$577K
Insider Sales
7
$154K
Total Volume
$732K
8 transactions
Net Activity
+$423K
Net buying
Sentiment Rating
Moderate AccumulationCEO Conviction Index
No Recent Signal
Key Drivers
- •Strong buying bias: purchases represent 79% of total transaction value.
Score Methodology
The Insider Confidence Score (1-100) measures executive conviction. Starting from a neutral 50, it adjusts based on:
- +15Strong Buy Ratio: Purchases > 70% of volume (or up to -15 for heavy sales).
- +20Cluster Buying: ≥3 unique insiders buying within a 30-day window.
- +15CEO Buying: CEO committing own capital shows high conviction.
- +10CFO Buying: CFO purchasing shares shows financial alignment.
Hagler Mark Arnold
See Remarks
$577K total
Cao Sean Wuxiong
Chief Bus. Development Officer
$122K total
Xu Cong Claire
EVP, Clinical Development
$20K total
Dennis Phillip Andrew
Chief Medical Officer
$11K total
Quick Actions
NBP has an insider buy conviction of 79%, compared to the Unknown sector buy average of 6%.
Over the last 90 days, corporate insiders at NBP (NBP) engaged in a total of 8 transactions reported via SEC Form 4 filings. Among these, 1 were open-market purchases and 7 were sales. The total volume of insider trading reached $732K.
The net insider activity for NBP shows a net buying bias of $423K. This activity represents a 79% buy ratio, suggesting that insiders are currently strongly bullish on the company's near-term outlook relative to recent history.
The most notable individual transaction was a Purchase by Hagler Mark Arnold (See Remarks), who traded 230.0K shares valued at $577K on Apr 24, 2026.
NovaBridge Biosciences (NBP) Stock Price, News, Quote & History
NovaBridge Biosciences (Nasdaq:NBP) - Stock Analysis
NovaBridge Biosciences (NBP) stock price, news, quote and history
NBP Stock Discussion and Investor Sentiment - National Bank Of Pakistan
A trial will test if patients can wait up to seven months between eye injections after three monthly doses.
NovaBridge: Rebranded, Repackaged, But Far From De-Risked (NASDAQ:NBP)
FAQs About NBP Insider Trading
Answers to common questions regarding corporate filings and executive sentiment for NBP.